| Year |
Citation |
Score |
| 2020 |
Cho C, Mukherjee R, Peck AR, Sun Y, McBrearty N, Katlinski KV, Gui J, Govindaraju PK, Puré E, Rui H, Fuchs SY. Cancer-associated fibroblasts downregulate type I interferon receptor to stimulate intratumoral stromagenesis. Oncogene. PMID 32807917 DOI: 10.1038/S41388-020-01424-7 |
0.368 |
|
| 2020 |
Yang G, Zhang J, Jiang T, Monslow J, Yew Tang S, Todd L, Puré E, Chen L, FitzGerald GA. Bmal1 (Brain and Muscle Aryl Hydrocarbon Receptor Nuclear-Like 1) Deletion in Myeloid Cells Attenuates Atherosclerotic Lesion Development and Restrains Abdominal Aortic Aneurysm Formation in Hyperlipidemic Mice. Arteriosclerosis, Thrombosis, and Vascular Biology. ATVBAHA120314318. PMID 32321308 DOI: 10.1161/Atvbaha.120.314318 |
0.39 |
|
| 2020 |
Monslow J, Todd L, Chojnowski JE, Govindaraju PK, Assoian RK, Puré E. Fibroblast activation protein regulates lesion burden and the fibro-inflammatory response in Apoe-deficient mice in a sexually dimorphic manner. The American Journal of Pathology. PMID 32084369 DOI: 10.1016/J.Ajpath.2020.01.004 |
0.378 |
|
| 2020 |
Noguera-Ortega E, Todd L, Monslow J, Sun J, Albelda SM, Pure E. Abstract A62: Inhibition of tumor growth by novel CART redirected against cells expressing high levels of fibroblast activation protein Cancer Immunology Research. 8. DOI: 10.1158/2326-6074.Tumimm19-A62 |
0.363 |
|
| 2020 |
Pure E. Abstract PL1: Stromal Cells and Matrix Remodeling as Essential Regulators of the Tumor Microenvironment Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-Pl1 |
0.388 |
|
| 2019 |
Aghajanian H, Kimura T, Rurik JG, Hancock AS, Leibowitz MS, Li L, Scholler J, Monslow J, Lo A, Han W, Wang T, Bedi K, Morley MP, Linares Saldana RA, Bolar NA, et al. Targeting cardiac fibrosis with engineered T cells. Nature. PMID 31511695 DOI: 10.1038/S41586-019-1546-Z |
0.302 |
|
| 2019 |
Kwon MY, Wang C, Galarraga JH, Puré E, Han L, Burdick JA. Influence of hyaluronic acid modification on CD44 binding towards the design of hydrogel biomaterials. Biomaterials. 222: 119451. PMID 31480001 DOI: 10.1016/J.Biomaterials.2019.119451 |
0.313 |
|
| 2019 |
Blomberg R, Beiting DP, Wabitsch M, Puré E. Fibroblast activation protein restrains adipogenic differentiation and regulates matrix-mediated mTOR signaling. Matrix Biology : Journal of the International Society For Matrix Biology. PMID 31325484 DOI: 10.1016/J.Matbio.2019.07.007 |
0.324 |
|
| 2019 |
Lieberman A, Barrett R, Kim J, Zhang KL, Avery D, Monslow J, Kim H, Kim BJ, Pure E, Ryeom S. Deletion of calcineurin promotes a pro-tumorigenic fibroblast phenotype. Cancer Research. PMID 31189649 DOI: 10.1158/0008-5472.Can-19-0056 |
0.376 |
|
| 2019 |
Kimura T, Monslow J, Klampatsa A, Leibowitz M, Sun J, Liousia M, Woodruff P, Moon E, Todd L, Pure E, Albelda SM. Loss of cells expressing Fibroblast Activation Protein (FAP) has variable effects in models of TGF-β and chronic bleomycin-induced fibrosis. American Journal of Physiology. Lung Cellular and Molecular Physiology. PMID 31188013 DOI: 10.1152/Ajplung.00071.2019 |
0.373 |
|
| 2018 |
Cremasco V, Astarita JL, Grauel AL, Keerthivasan S, MacIsaac KD, Woodruff MC, Wu M, Spel L, Santoro S, Amoozgar Z, Laszewski T, Cruz-Migoni S, Knoblich K, Fletcher AL, LaFleur M, ... ... Pure E, et al. FAP delineates heterogeneous and functionally divergent stromal cells in immune-excluded breast tumors. Cancer Immunology Research. PMID 30266714 DOI: 10.1158/2326-6066.Cir-18-0098 |
0.361 |
|
| 2018 |
Govindaraju P, Todd L, Shetye S, Monslow J, Puré E. CD44-dependent inflammation, fibrogenesis, and collagenolysis regulates extracellular matrix remodeling and tensile strength during cutaneous wound healing. Matrix Biology : Journal of the International Society For Matrix Biology. PMID 29894820 DOI: 10.1016/J.Matbio.2018.06.004 |
0.356 |
|
| 2018 |
Krolikoski M, Monslow J, Puré E. The CD44-HA axis and inflammation in atherosclerosis: A temporal perspective. Matrix Biology : Journal of the International Society For Matrix Biology. PMID 29792915 DOI: 10.1016/J.Matbio.2018.05.007 |
0.344 |
|
| 2017 |
Avery D, Govindaraju P, Jacob M, Todd L, Monslow J, Puré E. Extracellular matrix directs phenotypic heterogeneity of activated fibroblasts. Matrix Biology : Journal of the International Society For Matrix Biology. PMID 29248556 DOI: 10.1016/J.Matbio.2017.12.003 |
0.328 |
|
| 2017 |
Razinia Z, Castagnino P, Xu T, Vázquez-Salgado A, Puré E, Assoian RK. Stiffness-dependent motility and proliferation uncoupled by deletion of CD44. Scientific Reports. 7: 16499. PMID 29184125 DOI: 10.1038/S41598-017-16486-Z |
0.355 |
|
| 2017 |
Kumar V, Donthireddy L, Marvel D, Condamine T, Wang F, Lavilla-Alonso S, Hashimoto A, Vonteddu P, Behera R, Goins MA, Mulligan C, Nam B, Hockstein N, Denstman F, Shakamuri S, et al. Cancer-Associated Fibroblasts Neutralize the Anti-tumor Effect of CSF1 Receptor Blockade by Inducing PMN-MDSC Infiltration of Tumors. Cancer Cell. 32: 654-668.e5. PMID 29136508 DOI: 10.1016/J.Ccell.2017.10.005 |
0.302 |
|
| 2017 |
Lo A, Li CP, Buza EL, Blomberg R, Govindaraju P, Avery D, Monslow J, Hsiao M, Puré E. Fibroblast activation protein augments progression and metastasis of pancreatic ductal adenocarcinoma. Jci Insight. 2. PMID 28978805 DOI: 10.1172/Jci.Insight.92232 |
0.398 |
|
| 2017 |
Katlinski KV, Gui J, Katlinskaya YV, Ortiz A, Chakraborty R, Bhattacharya S, Carbone CJ, Beiting DP, Girondo MA, Peck AR, Puré E, Chatterji P, Rustgi AK, Diehl JA, Koumenis C, et al. Inactivation of Interferon Receptor Promotes the Establishment of Immune Privileged Tumor Microenvironment. Cancer Cell. 31: 194-207. PMID 28196594 DOI: 10.1016/J.Ccell.2017.01.004 |
0.324 |
|
| 2016 |
Tang SY, Monslow J, Grant GR, Todd L, Pawelzik SC, Chen L, Lawson J, Puré E, FitzGerald GA. Cardiovascular Consequences of Prostanoid I Receptor Deletion in Microsomal Prostaglandin E Synthase-1 Deficient Hyperlipidemic Mice. Circulation. PMID 27440004 DOI: 10.1161/Circulationaha.116.022308 |
0.35 |
|
| 2016 |
Albelda SM, Newick K, O'Brien S, Sun J, Kapoor V, Maceyko S, Lo A, Pure E, Moon EK. Augmentation of CAR T cell trafficking and antitumor efficacy by blocking protein kinase A (PKA) localization. Cancer Immunology Research. PMID 27045023 DOI: 10.1158/2326-6066.Cir-15-0263 |
0.36 |
|
| 2016 |
Puré E, Lo A. Can Targeting Stroma Pave the Way to Enhanced Antitumor Immunity and Immunotherapy of Solid Tumors? Cancer Immunology Research. 4: 269-78. PMID 27036971 DOI: 10.1158/2326-6066.Cir-16-0011 |
0.352 |
|
| 2016 |
Puré E, Krolikoski M, Monslow J. Role for Hyaluronan Synthase 3 in the Response to Vascular Injury. Arteriosclerosis, Thrombosis, and Vascular Biology. 36: 224-5. PMID 26819465 DOI: 10.1161/Atvbaha.115.306869 |
0.319 |
|
| 2016 |
Puré E. Abstract IA18: Tumor stroma: Immunomodulatory functions and a target of immunotherapy Cancer Immunology Research. 4. DOI: 10.1158/2326-6074.Cricimteatiaacr15-Ia18 |
0.368 |
|
| 2016 |
Newick K, O'Brien S, Sun J, Kapoor V, Maceyko S, Lo A, Pure E, Moon EK, Albelda SM. Abstract B27: Blockade of protein kinase A (PKA) localization augments the trafficking and anti-tumor efficacy of adoptively transferred chimeric antigen receptor-expressing T cells Cancer Research. 76. DOI: 10.1158/1538-7445.Tme16-B27 |
0.361 |
|
| 2015 |
Monslow J, Govindaraju P, Puré E. Hyaluronan - a functional and structural sweet spot in the tissue microenvironment. Frontiers in Immunology. 6: 231. PMID 26029216 DOI: 10.3389/Fimmu.2015.00231 |
0.311 |
|
| 2015 |
Lo A, Wang LC, Scholler J, Monslow J, Avery D, Newick K, O'Brien S, Evans RA, Bajor DJ, Clendenin C, Durham AC, Buza EL, Vonderheide RH, June CH, Albelda SM, et al. Tumor-Promoting Desmoplasia Is Disrupted by Depleting FAP-Expressing Stromal Cells. Cancer Research. 75: 2800-10. PMID 25979873 DOI: 10.1158/0008-5472.Can-14-3041 |
0.361 |
|
| 2015 |
Wang E, Wang LC, Tsai CY, Bhoj V, Gershenson Z, Moon E, Newick K, Sun J, Lo A, Baradet T, Feldman MD, Barrett D, Puré E, Albelda S, Milone MC. Generation of Potent T-cell Immunotherapy for Cancer Using DAP12-Based, Multichain, Chimeric Immunoreceptors. Cancer Immunology Research. 3: 815-26. PMID 25941351 DOI: 10.1158/2326-6066.Cir-15-0054 |
0.333 |
|
| 2015 |
Brisson BK, Mauldin EA, Lei W, Vogel LK, Power AM, Lo A, Dopkin D, Khanna C, Wells RG, Puré E, Volk SW. Type III Collagen Directs Stromal Organization and Limits Metastasis in a Murine Model of Breast Cancer. The American Journal of Pathology. 185: 1471-86. PMID 25795282 DOI: 10.1016/J.Ajpath.2015.01.029 |
0.359 |
|
| 2015 |
Eisinger-Mathason TSK, Zhang M, Qiong Q, Skuli N, Nakazawa MS, Karakasheva T, Mucaj V, Shay JES, Stangenberg L, Pure E, Yoon SS, Kirsch DG, Simon MC. Abstract A41: Hypoxia-dependent modification of collagen networks promotes sarcoma metastasis Cancer Research. 75. DOI: 10.1158/1538-7445.Chtme14-A41 |
0.337 |
|
| 2015 |
Avery D, Jacob M, Chang L, Todd L, Pure E. Abstract LB-206: The role of fibroblast activation protein (FAP) in lung tumorigenesis Cancer Research. 75. DOI: 10.1158/1538-7445.Am2015-Lb-206 |
0.355 |
|
| 2015 |
Lo A, Wang LS, Scholler J, Monslow J, Avery D, Evans RA, Bajor DJ, Durham AC, Buza EL, Vonderheide RH, June CH, Albelda SM, Puré E. Abstract 3187: Depleting cells expressing fibroblast activation protein disrupts tumor-promoting desmoplasia Immunology. 75: 3187-3187. DOI: 10.1158/1538-7445.Am2015-3187 |
0.333 |
|
| 2014 |
Moon EK, Wang LC, Dolfi DV, Wilson CB, Ranganathan R, Sun J, Kapoor V, Scholler J, Puré E, Milone MC, June CH, Riley JL, Wherry EJ, Albelda SM. Multifactorial T-cell hypofunction that is reversible can limit the efficacy of chimeric antigen receptor-transduced human T cells in solid tumors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 4262-73. PMID 24919573 DOI: 10.1158/1078-0432.Ccr-13-2627 |
0.315 |
|
| 2014 |
Wang LC, Lo A, Scholler J, Sun J, Majumdar RS, Kapoor V, Antzis M, Cotner CE, Johnson LA, Durham AC, Solomides CC, June CH, Puré E, Albelda SM. Targeting fibroblast activation protein in tumor stroma with chimeric antigen receptor T cells can inhibit tumor growth and augment host immunity without severe toxicity. Cancer Immunology Research. 2: 154-66. PMID 24778279 DOI: 10.1158/2326-6066.Cir-13-0027 |
0.369 |
|
| 2014 |
Chen L, Yang G, Monslow J, Todd L, Cormode DP, Tang J, Grant GR, DeLong JH, Tang SY, Lawson JA, Pure E, Fitzgerald GA. Myeloid cell microsomal prostaglandin E synthase-1 fosters atherogenesis in mice. Proceedings of the National Academy of Sciences of the United States of America. 111: 6828-33. PMID 24753592 DOI: 10.1073/Pnas.1401797111 |
0.398 |
|
| 2013 |
Tchou J, Zhang PJ, Bi Y, Satija C, Marjumdar R, Stephen TL, Lo A, Chen H, Mies C, June CH, Conejo-Garcia J, Puré E. Fibroblast activation protein expression by stromal cells and tumor-associated macrophages in human breast cancer. Human Pathology. 44: 2549-57. PMID 24074532 DOI: 10.1016/J.Humpath.2013.06.016 |
0.327 |
|
| 2013 |
Licciulli S, Avila JL, Hanlon L, Troutman S, Cesaroni M, Kota S, Keith B, Simon MC, Puré E, Radtke F, Capobianco AJ, Kissil JL. Notch1 is required for Kras-induced lung adenocarcinoma and controls tumor cell survival via p53. Cancer Research. 73: 5974-84. PMID 23943799 DOI: 10.1158/0008-5472.Can-13-1384 |
0.302 |
|
| 2013 |
Eisinger-Mathason TS, Zhang M, Qiu Q, Skuli N, Nakazawa MS, Karakasheva T, Mucaj V, Shay JE, Stangenberg L, Sadri N, Puré E, Yoon SS, Kirsch DG, Simon MC. Hypoxia-dependent modification of collagen networks promotes sarcoma metastasis. Cancer Discovery. 3: 1190-205. PMID 23906982 DOI: 10.1158/2159-8290.Cd-13-0118 |
0.307 |
|
| 2013 |
El-Dakdouki MH, Puré E, Huang X. Development of drug loaded nanoparticles for tumor targeting. Part 2: Enhancement of tumor penetration through receptor mediated transcytosis in 3D tumor models. Nanoscale. 5: 3904-11. PMID 23549322 DOI: 10.1039/C3Nr90022C |
0.313 |
|
| 2013 |
El-Dakdouki MH, Puré E, Huang X. Development of drug loaded nanoparticles for tumor targeting. Part 1: Synthesis, characterization, and biological evaluation in 2D cell cultures. Nanoscale. 5: 3895-903. PMID 23529646 DOI: 10.1039/C3Nr33777D |
0.31 |
|
| 2013 |
Wang LS, Lo A, Scholler J, June CH, Pure E, Albelda SM. Abstract PR14: Fibroblast activation protein as a universal target for chimeric antigen receptor T cell therapy in solid tumors. Cancer Research. 73. DOI: 10.1158/1538-7445.Tumimm2012-Pr14 |
0.365 |
|
| 2012 |
Puré E, Kinder M. Hematopoietic defects in 12/15-lipoxygenase-deficient mice Blood. 119: 6174-6175. DOI: 10.1182/Blood-2012-04-417436 |
0.73 |
|
| 2011 |
Tchou J, Satija C, Zhang P, Bi Y, Davuluri R, Chen H, Majumdar R, Mies C, Herlyn M, Pure E. P1-03-09: Significance of FAP, SMA and CD31 Expression in the Stroma of Breast Cancer. Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-P1-03-09 |
0.343 |
|
| 2010 |
Kinder M, Thompson JE, Wei C, Shelat SG, Blair IA, Carroll M, Puré E. Interferon regulatory factor-8-driven myeloid differentiation is regulated by 12/15-lipoxygenase-mediated redox signaling. Experimental Hematology. 38: 1036-1046.e1-4. PMID 20647030 DOI: 10.1016/J.Exphem.2010.07.004 |
0.745 |
|
| 2010 |
Kinder M, Wei C, Shelat SG, Kundu M, Zhao L, Blair IA, Puré E. Hematopoietic stem cell function requires 12/15-lipoxygenase-dependent fatty acid metabolism Blood. 115: 5012-5022. PMID 20357242 DOI: 10.1182/Blood-2009-09-243139 |
0.737 |
|
| 2009 |
Santos AM, Jung J, Aziz N, Kissil JL, Puré E. Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice. The Journal of Clinical Investigation. 119: 3613-25. PMID 19920354 DOI: 10.1172/Jci38988 |
0.359 |
|
| 2009 |
Middleton MK, Zukas AM, Rubinstein T, Kinder M, Wilson EH, Zhu P, Blair IA, Hunter CA, Puré E. 12/15-lipoxygenase-dependent myeloid production of interleukin-12 is essential for resistance to chronic toxoplasmosis. Infection and Immunity. 77: 5690-700. PMID 19822654 DOI: 10.1128/Iai.00560-09 |
0.726 |
|
| 2009 |
Puré E. The road to integrative cancer therapies: emergence of a tumor-associated fibroblast protease as a potential therapeutic target in cancer. Expert Opinion On Therapeutic Targets. 13: 967-73. PMID 19606930 DOI: 10.1517/14728220903103841 |
0.319 |
|
| 2009 |
Zhu L, Stalker TJ, Fong KP, Jiang H, Tran A, Crichton I, Lee EK, Neeves KB, Maloney SF, Kikutani H, Kumanogoh A, Pure E, Diamond SL, Brass LF. Disruption of SEMA4D ameliorates platelet hypersensitivity in dyslipidemia and confers protection against the development of atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology. 29: 1039-45. PMID 19390055 DOI: 10.1161/Atvbaha.109.185405 |
0.329 |
|
| 2009 |
Puré E, Assoian RK. Rheostatic signaling by CD44 and hyaluronan. Cellular Signalling. 21: 651-5. PMID 19174187 DOI: 10.1016/J.Cellsig.2009.01.024 |
0.331 |
|
| 2008 |
Mrass P, Kinjyo I, Ng LG, Reiner SL, Puré E, Weninger W. CD44 mediates successful interstitial navigation by killer T cells and enables efficient antitumor immunity. Immunity. 29: 971-85. PMID 19100702 DOI: 10.1016/J.Immuni.2008.10.015 |
0.357 |
|
| 2008 |
Kothapalli D, Flowers J, Xu T, Puré E, Assoian RK. Differential activation of ERK and Rac mediates the proliferative and anti-proliferative effects of hyaluronan and CD44. The Journal of Biological Chemistry. 283: 31823-9. PMID 18806267 DOI: 10.1074/Jbc.M802934200 |
0.354 |
|
| 2008 |
Zhao L, Lee E, Zukas AM, Middleton MK, Kinder M, Acharya PS, Hall JA, Rader DJ, Puré E. CD44 expressed on both bone marrow-derived and non-bone marrow-derived cells promotes atherogenesis in ApoE-deficient mice. Arteriosclerosis, Thrombosis, and Vascular Biology. 28: 1283-9. PMID 18420998 DOI: 10.1161/Atvbaha.108.165753 |
0.712 |
|
| 2008 |
Acharya PS, Majumdar S, Jacob M, Hayden J, Mrass P, Weninger W, Assoian RK, Puré E. Fibroblast migration is mediated by CD44-dependent TGF beta activation. Journal of Cell Science. 121: 1393-402. PMID 18397995 DOI: 10.1242/Jcs.021683 |
0.355 |
|
| 2007 |
Kothapalli D, Zhao L, Hawthorne EA, Cheng Y, Lee E, Puré E, Assoian RK. Hyaluronan and CD44 antagonize mitogen-dependent cyclin D1 expression in mesenchymal cells. The Journal of Cell Biology. 176: 535-44. PMID 17296798 DOI: 10.1083/Jcb.200611058 |
0.348 |
|
| 2007 |
Zhao L, Hall JA, Levenkova N, Lee E, Middleton MK, Zukas AM, Rader DJ, Rux JJ, Puré E. CD44 regulates vascular gene expression in a proatherogenic environment. Arteriosclerosis, Thrombosis, and Vascular Biology. 27: 886-92. PMID 17272751 DOI: 10.1161/01.Atv.0000259362.10882.C5 |
0.71 |
|
| 2006 |
Middleton MK, Zukas AM, Rubinstein T, Jacob M, Zhu P, Zhao L, Blair I, Puré E. Identification of 12/15-lipoxygenase as a suppressor of myeloproliferative disease. The Journal of Experimental Medicine. 203: 2529-40. PMID 17043146 DOI: 10.1084/Jem.20061444 |
0.729 |
|
| 2006 |
Middleton MK, Rubinstein T, Puré E. Cellular and molecular mechanisms of the selective regulation of IL-12 production by 12/15-lipoxygenase. Journal of Immunology (Baltimore, Md. : 1950). 176: 265-74. PMID 16365418 DOI: 10.4049/Jimmunol.176.1.265 |
0.727 |
|
| 2005 |
Ali K, Middleton M, Puré E, Rader DJ. Apolipoprotein E suppresses the type I inflammatory response in vivo. Circulation Research. 97: 922-7. PMID 16179587 DOI: 10.1161/01.Res.0000187467.67684.43 |
0.742 |
|
| 2005 |
Cichy J, Kulig P, Puré E. Regulation of the release and function of tumor cell-derived soluble CD44. Biochimica Et Biophysica Acta. 1745: 59-64. PMID 16085055 DOI: 10.1016/J.Bbamcr.2005.02.006 |
0.342 |
|
| 2004 |
Lavens S, Faust EA, Lu F, Jacob M, Leta M, Lieberman PM, Puré E. Identification of protein tyrosine kinases required for B-cell- receptor-mediated activation of an Epstein-Barr Virus immediate-early gene promoter. Journal of Virology. 78: 8543-51. PMID 15280463 DOI: 10.1128/Jvi.78.16.8543-8551.2004 |
0.33 |
|
| 2004 |
Sague SL, Tato C, Puré E, Hunter CA. The regulation and activation of CD44 by natural killer (NK) cells and its role in the production of IFN-gamma. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 24: 301-9. PMID 15153314 DOI: 10.1089/107999004323065093 |
0.387 |
|
| 2004 |
Cichy J, Puré E. Cytokines regulate the affinity of soluble CD44 for hyaluronan. Febs Letters. 556: 69-74. PMID 14706828 DOI: 10.1016/S0014-5793(03)01370-X |
0.341 |
|
| 2003 |
Kothapalli D, Stewart SA, Smyth EM, Azonobi I, Pure E, Assoian RK. Prostacylin receptor activation inhibits proliferation of aortic smooth muscle cells by regulating cAMP response element-binding protein- and pocket protein-dependent cyclin a gene expression. Molecular Pharmacology. 64: 249-58. PMID 12869629 DOI: 10.1124/Mol.64.2.249 |
0.309 |
|
| 2003 |
Cichy J, Puré E. The liberation of CD44. The Journal of Cell Biology. 161: 839-43. PMID 12796473 DOI: 10.1083/Jcb.200302098 |
0.343 |
|
| 2002 |
Wang X, Xu L, Wang H, Zhan Y, Puré E, Feuerstein GZ. CD44 deficiency in mice protects brain from cerebral ischemia injury. Journal of Neurochemistry. 83: 1172-9. PMID 12437588 DOI: 10.1046/J.1471-4159.2002.01225.X |
0.381 |
|
| 2002 |
Teder P, Vandivier RW, Jiang D, Liang J, Cohn L, Puré E, Henson PM, Noble PW. Resolution of lung inflammation by CD44. Science (New York, N.Y.). 296: 155-8. PMID 11935029 DOI: 10.1126/Science.1069659 |
0.346 |
|
| 2001 |
Cuff CA, Kothapalli D, Azonobi I, Chun S, Zhang Y, Belkin R, Yeh C, Secreto A, Assoian RK, Rader DJ, Puré E. The adhesion receptor CD44 promotes atherosclerosis by mediating inflammatory cell recruitment and vascular cell activation. The Journal of Clinical Investigation. 108: 1031-40. PMID 11581304 DOI: 10.1172/Jci12455 |
0.396 |
|
| 2001 |
Blass SL, Puré E, Hunter CA. A role for CD44 in the production of IFN-γ and immunopathology during infection with Toxoplasma gondii Journal of Immunology. 166: 5726-5732. PMID 11313415 DOI: 10.4049/Jimmunol.166.9.5726 |
0.398 |
|
| 2000 |
Detmers PA, Hernandez M, Mudgett J, Hassing H, Burton C, Mundt S, Chun S, Fletcher D, Card DJ, Lisnock JM, Weikel R, Bergstrom JD, Shevell DE, Hermanowski-Vosatka A, Sparrow CP, ... ... Pure E, et al. Deficiency in inducible nitric oxide synthase results in reduced atherosclerosis in apolipoprotein E-deficient mice Journal of Immunology. 165: 3430-3435. PMID 10975863 DOI: 10.4049/Jimmunol.165.6.3430 |
0.358 |
|
| 2000 |
Tsukamoto K, Tangirala RK, Chun S, Usher D, Puré E, Rader DJ. Hepatic expression of apolipoprotein E inhibits progression of atherosclerosis without reducing cholesterol levels in LDL receptor-deficient mice. Molecular Therapy : the Journal of the American Society of Gene Therapy. 1: 189-94. PMID 10933930 DOI: 10.1006/Mthe.2000.0028 |
0.343 |
|
| 1999 |
Tangirala RK, Tsukamoto K, Chun SH, Usher D, Puré E, Rader DJ. Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice. Circulation. 100: 1816-22. PMID 10534470 DOI: 10.1161/01.Cir.100.17.1816 |
0.305 |
|
| 1999 |
Li HL, Davis WW, Whiteman EL, Birnbaum MJ, Puré E. The tyrosine kinases Syk and Lyn exert opposing effects on the activation of protein kinase Akt/PKB in B lymphocytes. Proceedings of the National Academy of Sciences of the United States of America. 96: 6890-5. PMID 10359809 DOI: 10.1073/Pnas.96.12.6890 |
0.347 |
|
| 1999 |
Noorchashm H, Bui A, Li HL, Eaton A, Mandik-Nayak L, Sokol C, Potts KM, Puré E, Erikson J. Characterization of anergic anti-DNA B cells: B cell anergy is a T cell-independent and potentially reversible process. International Immunology. 11: 765-76. PMID 10330282 DOI: 10.1093/Intimm/11.5.765 |
0.338 |
|
| 1998 |
Hodge-Dufour J, Marino MW, Horton MR, Jungbluth A, Burdick MD, Strieter RM, Noble PW, Hunter CA, Puré E. Inhibition of interferon γ induced interleukin 12 production: A potential mechanism for the anti-inflammatory activities of tumor necrosis factor Proceedings of the National Academy of Sciences of the United States of America. 95: 13806-13811. PMID 9811882 DOI: 10.1073/Pnas.95.23.13806 |
0.371 |
|
| 1998 |
Cichy J, Rose-John S, Puré E. Regulation of the type II oncostatin M receptor expression in lung-derived epithelial cells Febs Letters. 429: 412-416. PMID 9662460 DOI: 10.1016/S0014-5793(98)00643-7 |
0.311 |
|
| 1997 |
Daugherty A, Puré E, Delfel-Butteiger D, Chen S, Leferovich J, Roselaar SE, Rader DJ. The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/- mice. The Journal of Clinical Investigation. 100: 1575-80. PMID 9294126 DOI: 10.1172/Jci119681 |
0.375 |
|
| 1997 |
Lazaar AL, Reitz HE, Panettieri RA, Peters SP, Pure E. Antigen receptor-stimulated peripheral blood and bronchoalveolar lavage-derived T cells induce MHC class II and ICAM-1 expression on human airway smooth muscle. American Journal of Respiratory Cell and Molecular Biology. 16: 38-45. PMID 8998077 DOI: 10.1165/Ajrcmb.16.1.8998077 |
0.349 |
|
| 1995 |
Puré E, Camp RL, Peritt D, Panettieri RA, Lazaar AL, Nayak S. Defective phosphorylation and hyaluronate binding of CD44 with point mutations in the cytoplasmic domain. The Journal of Experimental Medicine. 181: 55-62. PMID 7528778 DOI: 10.1084/Jem.181.1.55 |
0.351 |
|
| 1994 |
Lazaar AL, Albelda SM, Pilewski JM, Brennan B, Puré E, Panettieri RA. T lymphocytes adhere to airway smooth muscle cells via integrins and CD44 and induce smooth muscle cell DNA synthesis Journal of Experimental Medicine. 180: 807-816. PMID 7520473 DOI: 10.1084/Jem.180.3.807 |
0.374 |
|
| 1983 |
Pure E, Isakson PC, Kappler JW, Marrack P, Krammer PH, Vitetta ES. T cell-derived B cell growth and differentiation factors. Dichotomy between the responsiveness of B cells from adult and neonatal mice. The Journal of Experimental Medicine. 157: 600-12. PMID 6600488 DOI: 10.1084/Jem.157.2.600 |
0.353 |
|
| 1982 |
Isakson PC, Puré E, Vitetta ES, Krammer PH. T cell-derived B cell differentiation factor(s). Effect on the isotype switch of murine B cells. The Journal of Experimental Medicine. 155: 734-48. PMID 7038025 DOI: 10.1084/Jem.155.3.734 |
0.335 |
|
| 1981 |
Isakson PC, Pure E, Uhr JW, Vitetta ES. Induction of proliferation and differentiation of neoplastic B cells by anti-immunoglobulin and T-cell factors Proceedings of the National Academy of Sciences of the United States of America. 78: 2507-2511. PMID 6787608 DOI: 10.1073/Pnas.78.4.2507 |
0.351 |
|
| Show low-probability matches. |